June 11, 2020 / 11:37 AM / in 23 days

BRIEF-Reata Pharmaceuticals & Blackstone Life Sciences Announce $350 Million Strategic Investment

June 11 (Reuters) - Reata Pharmaceuticals Inc:

* REATA PHARMACEUTICALS, INC. AND BLACKSTONE LIFE SCIENCES ANNOUNCE $350 MILLION STRATEGIC INVESTMENT

* REATA PHARMACEUTICALS - FUNDS MANAGED BY BLACKSTONE LIFE SCIENCES WILL LEAD A $350 MILLION ROYALTY AND EQUITY INVESTMENT IN REATA

* REATA PHARMACEUTICALS - INVESTMENT BY BLACKSTONE LIFE SCIENCES INCLUDES $300 MILLION IN RETURN FOR ROYALTY PAYMENTS ON WORLDWIDE NET SALES OF BARDOXOLONE

* REATA PHARMACEUTICALS - FINANCING ALSO INCLUDES $50 MILLION INVESTMENT IN 340,793 SHARES OF REATA’S CLASS A COMMON STOCK AT $146.72 PER SHARE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below